NO20060561L - Peparater inneholdende sertoliceller og myoidceller og anvendelse av disse i celletransplantater - Google Patents
Peparater inneholdende sertoliceller og myoidceller og anvendelse av disse i celletransplantaterInfo
- Publication number
- NO20060561L NO20060561L NO20060561A NO20060561A NO20060561L NO 20060561 L NO20060561 L NO 20060561L NO 20060561 A NO20060561 A NO 20060561A NO 20060561 A NO20060561 A NO 20060561A NO 20060561 L NO20060561 L NO 20060561L
- Authority
- NO
- Norway
- Prior art keywords
- cells
- myoid
- compositions containing
- sertolic
- cell grafts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0683—Cells of the male genital tract, e.g. prostate, epididymis; Non-germinal cells from testis, e.g. Leydig cells, Sertoli cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/24—Genital tract cells, non-germinal cells from gonads
- C12N2502/246—Cells of the male genital tract, non-germinal testis cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Foreliggende oppfinnelse gjelder anvendelse av sertoli-celler og myoide celler for dannelse av et immunologisk privilegert sete i et pattedyr, slik at transplantasjon av celler som danner en biologisk faktor ved behandling av en sykdom som skyldes mangel på en slik biologisk faktor lettes. Farmasøytiske preparater som inneholder sertoli-celler og myoide celler samt terapeutiske fremgangsmåter som gjelder anvendelse av disse cellene tilveiebringes av foreliggende oppfinnelse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48496003P | 2003-07-03 | 2003-07-03 | |
PCT/US2004/021462 WO2005018540A2 (en) | 2003-07-03 | 2004-07-02 | Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20060561L true NO20060561L (no) | 2006-02-03 |
NO338745B1 NO338745B1 (no) | 2016-10-17 |
Family
ID=34215816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060561A NO338745B1 (no) | 2003-07-03 | 2006-02-03 | Farmasøytiske sammensetninger som omfatter sertoliceller og myoidceller og anvendelse av disse i celletransplantater. |
Country Status (7)
Country | Link |
---|---|
US (2) | US20050118145A1 (no) |
EP (1) | EP1648380B1 (no) |
JP (1) | JP4926703B2 (no) |
AU (1) | AU2004266126B8 (no) |
CA (2) | CA2531022C (no) |
NO (1) | NO338745B1 (no) |
WO (1) | WO2005018540A2 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7399751B2 (en) | 1999-11-04 | 2008-07-15 | Sertoli Technologies, Inc. | Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
CA2531022C (en) * | 2003-07-03 | 2014-09-09 | Jannette Dufour | Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
WO2007089572A2 (en) * | 2006-01-26 | 2007-08-09 | John Constance M | Proliferative primary human sertoli cell cultures and their applications |
EP2046351A2 (en) * | 2006-07-28 | 2009-04-15 | Sertocell Biotechnology (US) Corp. | Adult sertoli cells and uses thereof |
PL2470228T3 (pl) | 2009-08-28 | 2018-03-30 | Sernova Corporation | Sposoby i urządzenia do przeszczepiania komórek |
KR101986830B1 (ko) | 2017-09-07 | 2019-06-07 | 차의과학대학교 산학협력단 | 줄기세포 유래 세르톨리유사세포, 그 제조방법, 및 그의 용도 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4980286A (en) * | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
US5158874A (en) * | 1985-08-30 | 1992-10-27 | The United States Of America As Represented By The Department Of Health And Human Services | Determining metastic potential of tumor cells and isolating metastic tumor cells |
US4829000A (en) * | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
IL87737A (en) * | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
US5182111A (en) * | 1987-11-17 | 1993-01-26 | Boston University Research Foundation | In vivo delivery of active factors by co-cultured cell implants |
FR2638643B1 (fr) * | 1988-11-09 | 1991-04-12 | Transgene Sa | Sequence d'adn codant pour le facteur ix humain ou une proteine analogue, vecteur d'expression, cellules transformees, procede de preparation du facteur ix et produits obtenus correspondants |
US5082670A (en) * | 1988-12-15 | 1992-01-21 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
US5236838A (en) * | 1988-12-23 | 1993-08-17 | Genzyme Corporation | Enzymatically active recombinant glucocerebrosidase |
US5399346A (en) * | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5053332A (en) * | 1989-07-24 | 1991-10-01 | Cook Richard B | Agarose beads, preferably incorporating biological materials |
US5304603A (en) * | 1991-06-18 | 1994-04-19 | The Population Council | Leydig cell stimulator |
US5663304A (en) * | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
US5474905A (en) * | 1993-11-24 | 1995-12-12 | Research Corporation Technologies | Antibodies specific for streptococcus pneumoniae hemin/hemoglobin-binding antigens |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US5451660A (en) * | 1993-12-13 | 1995-09-19 | Genentech, Inc. | Method for purifying polypeptides |
US5849285A (en) * | 1994-04-13 | 1998-12-15 | Research Corporation Technologies, Inc. | Autoimmune disease treatment with sertoli cells and in vitro co-culture of mammal cells with sertoli cells |
EP0755258B1 (en) * | 1994-04-13 | 2002-01-23 | Research Corporation Technologies, Inc | Methods of treating disease using sertoli cells and allografts or xenografts |
US5958404A (en) * | 1994-04-13 | 1999-09-28 | Research Corporation Technologies, Inc. | Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line |
US5759536A (en) * | 1994-05-27 | 1998-06-02 | University Technology Corporation | Use of fas ligand to supress T-lymphocyte-mediated immune responses |
ZA961018B (en) * | 1995-02-08 | 1997-08-08 | Yamanouchi Europ Bv | Oral dosage-forms containing a beta-lactam antibiotic. |
US5830460A (en) * | 1995-03-13 | 1998-11-03 | University Of South Florida | Sertoli cells as transplantation facilitator for cell transplantation |
US5702700A (en) * | 1995-03-13 | 1997-12-30 | University Of South Florida | Sertoli cells as neurorecovery inducing cells for Parkinson's disease |
WO1996033264A1 (en) * | 1995-04-20 | 1996-10-24 | University Of South Florida | Purified and isolated sertoli cell aggregate |
US6037175A (en) * | 1996-03-12 | 2000-03-14 | The University Of South Florida | Method and media for enhancing cryopreservation of cells |
US6036951A (en) * | 1996-03-12 | 2000-03-14 | University Of South Florida | Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders |
US5969211A (en) * | 1996-04-19 | 1999-10-19 | Ther Regents Of The University Of California | Pantropic retroviral vectors for gene transfer in mollusks |
US20040086494A1 (en) * | 1996-10-07 | 2004-05-06 | John Constance Mary | Immune privileged cells for delivery of proteins and peptides |
US20020065212A1 (en) * | 1996-11-08 | 2002-05-30 | Selawry Helena P. | Methods of treating disease using sertoli cells and allografts or xenografts |
AU8679498A (en) * | 1997-08-05 | 1999-03-01 | Joslin Diabetes Center Inc. | Immunologically privileged cells and uses thereof |
US6734338B1 (en) * | 1997-11-14 | 2004-05-11 | Cedars-Sinai Medical Center | Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies |
US7294755B1 (en) * | 1997-11-14 | 2007-11-13 | Cedars-Sinai Medical Center | Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
US6316692B1 (en) * | 1997-11-14 | 2001-11-13 | Cedars Sinai Medical Center | Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies |
US7399751B2 (en) * | 1999-11-04 | 2008-07-15 | Sertoli Technologies, Inc. | Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
SI20847B (sl) * | 1998-12-15 | 2009-04-30 | Univ Mexico Nacional Autonoma | Postopek in naprava za zaščito biološkega vsadka |
US6303355B1 (en) * | 1999-03-22 | 2001-10-16 | Duke University | Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
US6365385B1 (en) * | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
US6790441B1 (en) * | 2000-06-13 | 2004-09-14 | University Of South Florida | Sertoli cells as biochambers |
WO2002032437A1 (en) * | 2000-10-17 | 2002-04-25 | Diatranz Limited | Preparation and xenotransplantation or porcine islets |
JP4866535B2 (ja) * | 2001-05-11 | 2012-02-01 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 動物で用いるに適した免疫調節用デバイス |
WO2003027270A1 (en) * | 2001-09-28 | 2003-04-03 | Diabcell Pty Limited | Growing xenotransplant material in culture |
CA2476214A1 (en) * | 2002-02-08 | 2003-08-14 | University Of South Florida | Proliferated cell lines and uses thereof |
US20040062753A1 (en) * | 2002-09-27 | 2004-04-01 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
US20040156878A1 (en) * | 2003-02-11 | 2004-08-12 | Alireza Rezania | Implantable medical device seeded with mammalian cells and methods of treatment |
US20040197374A1 (en) * | 2003-04-02 | 2004-10-07 | Alireza Rezania | Implantable pouch seeded with insulin-producing cells to treat diabetes |
US20040197375A1 (en) * | 2003-04-02 | 2004-10-07 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
CA2531022C (en) * | 2003-07-03 | 2014-09-09 | Jannette Dufour | Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
US7625581B2 (en) * | 2003-12-19 | 2009-12-01 | Ethicon, Inc. | Tissue scaffolds for use in muscoloskeletal repairs |
US20070065422A1 (en) * | 2005-09-20 | 2007-03-22 | Cameron Don F | Induction of immune tolerance by sertoli cells |
EP2046351A2 (en) * | 2006-07-28 | 2009-04-15 | Sertocell Biotechnology (US) Corp. | Adult sertoli cells and uses thereof |
-
2004
- 2004-07-02 CA CA2531022A patent/CA2531022C/en not_active Expired - Fee Related
- 2004-07-02 WO PCT/US2004/021462 patent/WO2005018540A2/en active Application Filing
- 2004-07-02 JP JP2006518816A patent/JP4926703B2/ja not_active Expired - Fee Related
- 2004-07-02 CA CA2848954A patent/CA2848954A1/en not_active Abandoned
- 2004-07-02 AU AU2004266126A patent/AU2004266126B8/en not_active Ceased
- 2004-07-02 US US10/883,888 patent/US20050118145A1/en not_active Abandoned
- 2004-07-02 EP EP04777533.3A patent/EP1648380B1/en not_active Expired - Lifetime
-
2006
- 2006-02-03 NO NO20060561A patent/NO338745B1/no not_active IP Right Cessation
-
2008
- 2008-05-09 US US12/118,453 patent/US20090162331A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2004266126A1 (en) | 2005-03-03 |
WO2005018540A3 (en) | 2006-08-24 |
AU2004266126B8 (en) | 2011-07-28 |
WO2005018540A2 (en) | 2005-03-03 |
EP1648380A4 (en) | 2009-12-02 |
CA2531022C (en) | 2014-09-09 |
EP1648380B1 (en) | 2015-04-08 |
CA2531022A1 (en) | 2005-03-03 |
NO338745B1 (no) | 2016-10-17 |
CA2848954A1 (en) | 2005-03-03 |
JP4926703B2 (ja) | 2012-05-09 |
AU2004266126B2 (en) | 2011-06-09 |
JP2007530416A (ja) | 2007-11-01 |
US20090162331A1 (en) | 2009-06-25 |
EP1648380A2 (en) | 2006-04-26 |
US20050118145A1 (en) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR123811A2 (es) | Composiciones de células madre mesenquimáticas purificadas y métodos relacionados | |
ATE491454T1 (de) | Verwendung von pyrrolo-pyrazinderivaten zur behandlung der zystischen fibrose | |
CL2007003649A1 (es) | Un conjugado de molecula asociado a anticuerpo monoclonal humano anti-cd70; composicion que comprende al conjugado de molecula asociado a anticuerpo; metodo de inhibicion del crecimiento de celulas tumorales que expresan cd70. | |
NO20060561L (no) | Peparater inneholdende sertoliceller og myoidceller og anvendelse av disse i celletransplantater | |
NO20051030L (no) | Funksjonelle kardiomyocytter fra humane embryonale stamceller | |
EA200601231A1 (ru) | Дефинитивная энтодерма | |
NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
NO20092522L (no) | Sammensetninger og fremgangsmater for a behandle kreft med cupredoxiner og CPG rikt DNA | |
EA201070148A1 (ru) | Соединения и способы модулирования фарнезоидного рецептора x (fxr) | |
NO20073140L (no) | Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser | |
EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
NO20052595L (no) | Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser. | |
NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
NO20060360L (no) | Nye 8-azabisyklo [3.2.1] oktanderivater og deres anvendelse som monoaminneurotransmittergjenopptaksinhibitorer | |
ATE482213T1 (de) | Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine | |
NO20084396L (no) | Kombinasjonsterapi | |
EA200601995A1 (ru) | Pdx1-экспрессирующая энтодерма | |
MX2009005455A (es) | (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano. | |
DE60230327D1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
EA200800760A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
NO20074207L (no) | Substituted pyrido(2,3-d) pyrimidine derivatives and pharmaceutical compositions useful as medicines for the treatment of autoimmune disorders | |
CR9365A (es) | Compuestos y metodos para la inhibicion de la protein-cinasa raf | |
MX2007004551A (es) | Compuestos tiadiazol y metodos de uso. | |
NO20054769L (no) | Substituerte fenylalkansyrer | |
RU2009138327A (ru) | Композиции и способы направленного устранения мутационного ускользания в направленной терапии рака |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |